References
- Belser-Ehrlich S, Harper A, Hussey J, Hallock R. Human and cattle ergotism since 1900: symptoms, outbreaks, and regulations. Toxicol Ind Health 2013;29:307–316.
- Fröhlich G, Kaplan V, Amann-Vesti B. Holy fire in an HIV-positive man: a case of 21st-century ergotism. CMAJ 2010; 182:378–380.
- Ausband SC, Goodman PE. An unusual case of clarithromycin associated ergotism. J Emerg Med 2001; 21:411–413.
- Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 2000; 123:9–18.
- The World Bank [Internet]. Prevalence of HIV, total. Washington, DC: The World Bank Group; [cited 2014 Jan 20], Available from: http://www.data.worldbank.org/indicator/SH.DYN.AIDS.ZS
- El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, et al.; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283–2296.
- Food and Drug Administration [Internet]. Drug Development and Drug Interactions: Table of Substrates, Inhibitors, and Inducers. Bethesda, MD: US FDA, 2011. Available from: http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/druginteractionslabeling/ucm093664.htm. Accessed January 20, 2014.
- Hansteen V, Eika C, Birkeland S. Ergotism in a patient with a portosystemic shunt. Eur J Clin Pharmacol 1979; 16:425–426.
- Glazer G, Myers KA, Davies ER. Ergot poisoning. Postgrad Med J 1966; 42:562–568.
- Bas AY, Demirel N, Soysal A, Arslan K, Dilmen U. An unusual mimicker of a sepsis outbreak: ergot intoxication. Eur J Pediatr 2011; 170:633–637.
- Armenian P, Kearney TE. Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997–2008. Clin Toxicol (Phila) 2014; 52:214–219.
- Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003; 307:573–582.